Galmed reports 500% bioavailability boost for oral aramchol formulation
Go back to Galmed reports 500% bioavailability boost for oral aramchol formulation| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 0.59 +0.01 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.58 | 52 Week High | $9.70 | |||
| Open | $0.55 | 52 Week Low | $2.78 | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.53 | EPS | $0.00 | |||
| Volume | 739,246 | |||||
